| Literature DB >> 33391273 |
Christoph Ruschil1,2, Gisela Gabernet3, Gildas Lepennetier4, Simon Heumos3, Miriam Kaminski5, Zsuzsanna Hracsko6, Martin Irmler7, Johannes Beckers7,8,9, Ulf Ziemann1,2, Sven Nahnsen3, Gregory P Owens10, Jeffrey L Bennett11,12, Bernhard Hemmer4,13, Markus C Kowarik1,2,4.
Abstract
Double negative (DN) (CD19+CD20lowCD27-IgD-) B cells are expanded in patients with autoimmune and infectious diseases; however their role in the humoral immune response remains unclear. Using systematic flow cytometric analyses of peripheral blood B cell subsets, we observed an inflated DN B cell population in patients with variety of active inflammatory conditions: myasthenia gravis, Guillain-Barré syndrome, neuromyelitis optica spectrum disorder, meningitis/encephalitis, and rheumatic disorders. Furthermore, we were able to induce DN B cells in healthy subjects following vaccination against influenza and tick borne encephalitis virus. Transcriptome analysis revealed a gene expression profile in DN B cells that clustered with naïve B cells, memory B cells, and plasmablasts. Immunoglobulin VH transcriptome sequencing and analysis of recombinant antibodies revealed clonal expansion of DN B cells that were targeted against the vaccine antigen. Our study suggests that DN B cells are expanded in multiple inflammatory neurologic diseases and represent an inducible B cell population that responds to antigenic stimulation, possibly through an extra-follicular maturation pathway.Entities:
Keywords: B cells; TBE vaccination; autoimmune disorders ; double negative B cells; influenza vaccination; neuromyelitis optica spectrum disorder; vaccination
Mesh:
Substances:
Year: 2020 PMID: 33391273 PMCID: PMC7775384 DOI: 10.3389/fimmu.2020.606338
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561